Share this Post!

All comments can be sent at cdrr.od@fda.gov.ph. Deadline of submission of comments shall be by 08 January 2021.

Attachment:->Draft for Comments – Supplement to FDA Circular No.2014-016 Implementing Guidelines AO2013-0022 on the Renewal of cGMP Clearance